Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2BIAXIN

02 1BIAXIN XL

03 1CARDIZEM CD

04 2CLOPIDOGREL BISULFATE

05 1K-TAB

06 1MESALAMINE

07 1PAROXETINE HYDROCHLORIDE

08 1PENTASA

09 1PLAVIX

10 1PSEUDOEPHEDRINE HYDROCHLORIDE

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

CLOPIDOGREL BISULFATE

Drug : PLAVIX

Dosage Form : TABLET; ORAL

Application Number : 20839

Country : US

Patented : No

Sanofi Company Banner

02

arrow
2024 ACI Convention
Not Confirmed

CLARITHROMYCIN

Drug : BIAXIN XL

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 50775

Country : US

Patented : No

Abbvie Company Banner

05

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DILTIAZEM HYDROCHLORIDE

Drug : CARDIZEM CD

Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL

Application Number : 20062

Country : US

Patented : No

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

PAROXETINE HYDROCHLORIDE

Drug : PAROXETINE HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 204134

Country : US

Patented : No

blank

08

arrow
2024 ACI Convention
Not Confirmed

09

arrow
2024 ACI Convention
Not Confirmed

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

MESALAMINE

Drug : PENTASA

Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL

Application Number : 20049

Country : US

Patented : No

blank